Encompass Health Corp Files 8-K

Ticker: EHC · Form: 8-K · Filed: Jun 21, 2024 · CIK: 785161

Sentiment: neutral

Topics: regulation-fd, sec-filing, disclosure

Related Tickers: EHC

TL;DR

EHC filed a standard 8-K, no new material info, just keeping the SEC updated.

AI Summary

On June 21, 2024, Encompass Health Corporation (EHC) filed an 8-K to disclose information under Regulation FD. The filing itself does not contain specific financial figures or material events, but rather serves as a notification of ongoing reporting obligations and the company's status as a publicly traded entity on the New York Stock Exchange.

Why It Matters

This 8-K filing by Encompass Health Corporation is a routine disclosure that confirms their ongoing reporting requirements to the SEC, ensuring transparency for investors.

Risk Assessment

Risk Level: low — This is a routine regulatory filing with no new material information or events disclosed.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Encompass Health Corporation to comply with Regulation FD disclosure requirements and to report its status as a publicly traded company.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is June 21, 2024.

On which stock exchange is Encompass Health Corporation's common stock traded?

Encompass Health Corporation's common stock is traded on the New York Stock Exchange.

What is the trading symbol for Encompass Health Corporation's common stock?

The trading symbol for Encompass Health Corporation's common stock is EHC.

Does this 8-K filing contain specific financial results or material business updates?

No, this 8-K filing, as presented in the provided text, is a routine disclosure under Regulation FD and does not contain specific financial results or material business updates.

Filing Stats: 2,368 words · 9 min read · ~8 pages · Grade level 19.3 · Accepted 2024-06-21 10:00:55

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

ITEM 7.01. Regulation FD Disclosure. On June 21, 2024, Encompass Health Corporation (the "Company" or "Encompass Health") published an Investor Reference Book, a copy of which is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference (the "Investor Reference Book"). The Investor Reference Book addresses, among other things, an overview of the Company and its industry, its business outlook, its growth strategy, and its operational initiatives. The Investor Reference Book is available at http://investor.encompasshealth.com by clicking on an available link. The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein. Note Regarding Presentation of Non-GAAP Financial Measures The financial data contained in the Investor Reference Book include non-GAAP financial measures, including the Company's, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. The leverage ratio referenced therein is defined as the ratio of consolidated total debt to Adjusted EBITDA for the trailing four quarters. The Company believes its leverage ratio and Adjusted EBITDA are measures of its ability to service its debt and its ability to make capital expenditures. Additionally, the leverage ratio is a standard measurement used by investors to gauge the creditworthiness of an institution. The Company's credit agreement also includes a maximum leverage ratio financial covenant which allows the Company to deduct cash on hand from consolidated

Forward-Looking Statements

Forward-Looking Statements

01. Financial Statements and Exhibits

ITEM 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Encompass Health Corporation Investor Reference Book 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENCOMPASS HEALTH CORPORATION By: / S / D OUGLAS E. C OLTHARP Name: Douglas E. Coltharp Title: Executive Vice President and Chief Financial Officer Dated: June 21, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing